RhumbLine Advisers’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,624
Closed -$12.9K 4250
2024
Q2
$12.9K Sell
6,624
-17,375
-72% -$59K ﹤0.01% 3945
2024
Q1
$154K Buy
23,999
+924
+4% +$8.39K ﹤0.01% 3288
2023
Q4
$323K Sell
23,075
-199
-0.9% -$3.14K ﹤0.01% 2927
2023
Q3
$570K Buy
23,274
+20,485
+734% +$519K ﹤0.01% 2541
2023
Q2
$91.3K Buy
+2,789
New +$78.4K ﹤0.01% 3546

Other funds holding GNLX

RhumbLine Advisers's GNLX Position: Q3 2024 in Review

RhumbLine Advisers sold out of Genelux (GNLX) in Q3 2024, closing a stake of 6,624 shares — an estimated $12.9K sold.

RhumbLine Advisers first reported a position in GNLX in Q2 2023 and held it in 5 quarters. The position peaked at $570K in Q3 2023. 57 funds tracked by Wall St. Rank hold GNLX as of Q3 2024.

  • RhumbLine Advisers reported no remaining Genelux position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 6,624 Genelux shares in Q3 2024, an estimated $12.9K.
  • RhumbLine Advisers first reported a position in Genelux in Q2 2023 and held it in 5 quarters.
  • RhumbLine Advisers's Genelux position peaked at $570K in Q3 2023.
  • 57 funds tracked by Wall St. Rank held Genelux as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.